Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus reuteri DSM 17938 and Reduced Crying Duration

Research synthesisLow evidenceLarge effect3 studies · 2 beneficial · 1 neutral · 0 harmful

Across 3 studies, 2 reported beneficial effects, including a large-sized reduction in crying duration (WMD -51.3 h, CI95% -72.2 to -30.5 h, P < 0.0001) from a systematic review of 2242 infants with colic, while one small neutral RCT showed no statistically significant benefit in antibiotic-exposed neonates. The predominant effect size is large in the most robust study, but evidence is limited by the small number of studies. Effects were observed in infants with colic, with a median study duration of 42 days.

  • Studied populations: infants with colic

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. The beneficial findings are driven by one high-quality systematic review; the only RCT (n=89) did not achieve statistical significance, suggesting the effect may be less consistent in certain populations (e.g., antibiotic-exposed neonates). The beneficial review (2025) is low-quality (evidence score 1) and provides limited independent support.

Generated Jul 11, 2026
Doses used in studies
  • CFU/day: 100 million–1 billion (median 100 million, IQR 100 million550 million) 3 studies
Time to effect
Median: 6 weeks · IQR 6 weeks6 weeks · Range 6 weeks6 weeks — Reported in 1 of 3 studies
3 of 3 papers
Back to top